---
schema_version: "secwatch.filing_event.v1"
accession: "0001793229-24-000146"
form_type: "8-K"
ticker: "CTEV"
cik: "0001793229"
company_name: "Claritev Corp"
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:26:18.195622+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# MultiPlan posts Q3 net loss $391.5M on $361.6M goodwill impairment; revenue down 5.1%

## Summary
- Revenue $230.5M (-5.1% YoY); net loss $391.5M vs loss $24.1M in Q3 2023.
- Adjusted EBITDA $141.6M (down from $152.3M); Free Cash Flow $41.1M (down from $49.7M).
- Recorded $361.6M impairment charge for goodwill and indefinite-lived intangibles.
- Identified $6.4B potential medical cost savings in Q3, +10% YoY.
- Updated FY2024 guidance: revenues $930-940M (previous $935-955M), Adj. EBITDA $580-590M.

## SEC filing metadata
- accession: 0001793229-24-000146
- form_type: 8-K
- ticker: CTEV
- cik: 0001793229
- company_name: Claritev Corp
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1793229/000179322924000146/0001793229-24-000146-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1793229/000179322924000146/mpln-20241105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001793229-24-000146
- JSON: https://secwatch.observer/filing/0001793229-24-000146.json
- Plain text: https://secwatch.observer/filing/0001793229-24-000146.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.